Placenta previa and maternal hemorrhagic morbidity

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Health

Background:

• Placenta previa is a known risk factor for maternal hemorrhage.
• Existing literature often emphasizes placenta accreta, leaving previa-associated morbidity less characterized.
• Understanding previa's impact is crucial for managing obstetric complications.

Purpose of the Study:

• To characterize maternal morbidity specifically associated with placenta previa.
• To identify independent risk factors for hemorrhage in women with placenta previa.
• To differentiate previa's impact from that of placenta accreta.

Main Methods:

• Secondary cohort analysis of the NICHD Maternal-Fetal Medicine Units Network Cesarean Section Registry.
• Comparison of 496 women with placenta previa to 24,201 women without previa, excluding cases of placenta accreta.
• Evaluation of composite maternal hemorrhagic morbidity, non-hemorrhagic morbidities, and hemorrhage risk factors.

Main Results:

• Maternal hemorrhagic morbidity was significantly higher in women with placenta previa (19% vs. 7%).
• Increased rates of uterine atony, red blood cell transfusion, and hysterectomy were observed with previa.
• Pre-delivery anemia, thrombocytopenia, diabetes, magnesium use, and general anesthesia were identified as risk factors for hemorrhage in previa cases.

Conclusions:

• Placenta previa is an independent risk factor for maternal hemorrhagic morbidity.
• Certain identified risk factors for hemorrhage are modifiable, while others are inherent to the clinical condition.
• This study highlights the significant morbidity associated with placenta previa, independent of accreta.